Related Experiment Videos
Endothelial nitric oxide synthase gene polymorphism and ischemic heart disease
Mark S Spence1, Paul G McGlinchey, Chris C Patterson
1Regional Medical Cardiology Centre, Royal Victoria Hospital, Belfast, Northern Ireland, United Kingdom.
American Heart Journal
|November 4, 2004
Summary
This study found no evidence that the G894T polymorphism in the endothelial nitric oxide synthase (eNOS) gene is a risk factor for ischemic heart disease (IHD). Family-based association tests in an Irish population did not support a role for this eNOS gene variant in IHD development.
Area of Science:
- Genetics
- Cardiovascular Disease
- Molecular Biology
Background:
- Ischemic heart disease (IHD) is a leading global cause of mortality, driven by genetic and environmental factors.
- Endothelial nitric oxide (NO) is crucial for preventing atherosclerosis, the underlying process in IHD.
- The endothelial NO synthase (eNOS) gene produces NO; its polymorphisms may influence IHD risk by altering NO levels.
Purpose of the Study:
- To investigate the association between the G894T polymorphism of the eNOS gene and IHD.
- To clarify the conflicting results from previous case-control studies on this eNOS gene polymorphism and IHD.
- To assess the role of the eNOS G894T polymorphism in IHD within a well-defined Irish population using family-based association tests.
Main Methods:
- Recruited 1023 individuals from 388 families, including discordant sibships and parent-offspring trios.
- Employed family-based association tests, specifically the combined transmission disequilibrium test/sib-transmission disequilibrium test and the pedigree disequilibrium test.
- Analyzed linkage disequilibrium between the eNOS G894T polymorphism and IHD.
Main Results:
- Neither the combined transmission disequilibrium test/sib-transmission disequilibrium test nor the pedigree disequilibrium test showed a statistically significant excess transmission of either eNOS G894T allele to affected individuals.
- P-values for the analyses were P = .57 and P = .38, respectively, indicating no significant association.
- The results suggest the G894T polymorphism is not a significant risk factor for IHD in the studied population.
Conclusions:
- Family-based association tests, robust for complex diseases, revealed no significant role for the eNOS G894T polymorphism in IHD development.
- The findings do not support the hypothesis that variations in the eNOS G894T polymorphism contribute to the risk of ischemic heart disease.
- This study provides evidence against the G894T polymorphism as a genetic risk factor for IHD in the Irish population.